- Home
- ENOV
ENOV
Enovis Corporation
as 03-28-2025 3:35pm EST
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 2.1B | IPO Year: | 2008 |
| Target Price: | $58.50 | AVG Volume (30 days): | 931.0K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -14.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $35.14 - $62.79 | Next Earning Date: | 05-01-2025 |
| Revenue: | $2,107,623,000 | Revenue Growth: | 23.45% |
| Revenue Growth (this year): | 7.09% | Revenue Growth (next year): | 6.38% |
Latest Enovis Corporation News
ENOV Breaking Stock News: Dive into ENOV Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
ENOV: Rating increased to a HOLD
GlobeNewswire
4 days ago
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025
StockStory
11 days ago
3 Stocks Under $50 in the Doghouse
GlobeNewswire
23 days ago
Enovis to Participate in Upcoming Investor Conferences
Argus Research
24 days ago
ENOV: Lowering target price to $29.00
Simply Wall St.
a month ago
Enovis Full Year 2024 Earnings: EPS Misses Expectations
GuruFocus.com
a month ago
Enovis Corp (ENOV) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook
Thomson Reuters StreetEvents
a month ago
Q4 2024 Enovis Corp Earnings Call
Compare ENOV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ENOV Enovis Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.